Caciotti Anna, Donati Maria Alice, Adami Andrea, Guerrini Renzo, Zammarchi Enrico, Morrone Amelia
AOU Meyer, Metabolic and Muscular Unit, Clinic of Pediatric Neurology, Florence, Italy.
Eur J Gastroenterol Hepatol. 2008 Feb;20(2):118-21. doi: 10.1097/MEG.0b013e3282f172e6.
Hereditary fructose intolerance is caused by a deficiency of the aldolase B enzyme, which is expressed in the liver, small intestine and kidneys. Patients usually show a marked aversion to fruits and sweets; if, however, it is not diagnosed, persistent or incidental ingestion of fructose might be lethal. Our paper aims at improving the clinical and molecular characterizations of these patients, to avoid dangerous misdiagnoses.
Here we report the molecular results in an Italian cohort: on the occurrence of aldolase B mutations and, in particular, on the clinical and molecular characterization of a large family with recurrent hereditary fructose intolerance.
Patients included in our cohort showed the three most common mutations (p.A150P, p.A175D and p.N335K). Such molecular tests were enough to cover all the mutated alleles of hereditary fructose intolerance found in our patients. The allele frequencies of hereditary fructose intolerance mutations detected were 69.2% for p.A150P, 23.1% for p.A175D and 7.7% for p.N335K. The proband of the family with recurrence of the disease was heterozygous for the known p.A150P and p.A175D mutated alleles of the aldolase B gene. Molecular characterization of at-risk family members also identified the p.N335K mutation. In addition, the oldest affected patients exhibited mild clinical impairment.
Our results indicate that the diagnosis of hereditary fructose intolerance can be complicated by clinical and genetic intrafamilial variability. A knowledge of the clinical and geographical history of each family member is thus essential, to reduce potentially lethal misdiagnoses and to facilitate such patients to receive appropriate genetic counselling.
遗传性果糖不耐受是由醛缩酶B酶缺乏引起的,该酶在肝脏、小肠和肾脏中表达。患者通常对水果和甜食表现出明显的厌恶;然而,如果未被诊断出来,持续或偶然摄入果糖可能是致命的。我们的论文旨在改善这些患者的临床和分子特征,以避免危险的误诊。
在此我们报告一个意大利队列的分子研究结果:关于醛缩酶B突变的发生情况,特别是关于一个患有复发性遗传性果糖不耐受的大家族的临床和分子特征。
我们队列中的患者表现出三种最常见的突变(p.A150P、p.A175D和p.N335K)。此类分子检测足以涵盖我们患者中发现的遗传性果糖不耐受的所有突变等位基因。检测到的遗传性果糖不耐受突变的等位基因频率分别为:p.A150P为69.2%,p.A175D为23.1%,p.N335K为7.7%。该疾病复发家族的先证者对于醛缩酶B基因已知的p.A150P和p.A175D突变等位基因是杂合的。对有风险的家族成员进行分子特征分析还发现了p.N335K突变。此外,年龄最大的受影响患者表现出轻度的临床损害。
我们的结果表明,遗传性果糖不耐受的诊断可能因家族内临床和遗传变异性而变得复杂。因此,了解每个家庭成员的临床和地理病史对于减少潜在致命的误诊以及帮助此类患者接受适当的遗传咨询至关重要。